Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation
about
Emerging role of mast cells and macrophages in cardiovascular and metabolic diseasesMast cell modulation of the vascular and lymphatic endotheliumTranscription factor GATA1 is dispensable for mast cell differentiation in adult miceProtease Inhibitors in Tick Saliva: The Role of Serpins and Cystatins in Tick-host-Pathogen Interaction.Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing.IgE actions on CD4+ T cells, mast cells, and macrophages participate in the pathogenesis of experimental abdominal aortic aneurysms.Immunoglobulin E and mast cell proteases are potential risk factors of human pre-diabetes and diabetes mellitus.Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progressionMast cell proteases as pharmacological targetsAdventitial Tertiary Lymphoid Organs as Potential Source of MicroRNA Biomarkers for Abdominal Aortic AneurysmCathepsin L activity is essential to elastase perfusion-induced abdominal aortic aneurysms in miceMast cell restricted mouse and human tryptase·heparin complexes hinder thrombin-induced coagulation of plasma and the generation of fibrin by proteolytically destroying fibrinogenMast cell stabilization: novel medication for obesity and diabetes.Inflammatory Cell Infiltrates in Acute and Chronic Thoracic Aortic Dissection.Chemokine (C-C motif) receptor 2 mediates mast cell migration to abdominal aortic aneurysm lesions in mice.Asthma Associates With Human Abdominal Aortic Aneurysm and Rupture.Approaches for analyzing the roles of mast cells and their proteases in vivo.Pharmaceutical stabilization of mast cells attenuates experimental atherogenesis in low-density lipoprotein receptor-deficient mice.Analysis of Inflammatory Mediators in Prediabetes and Newly Diagnosed Type 2 Diabetes PatientsMast cell chymase and tryptase as targets for cardiovascular and metabolic diseases.Immunoglobulin E and mast cell proteases are potential risk factors of impaired fasting glucose and impaired glucose tolerance in humans.The adventitia: a progenitor cell niche for the vessel wall.Mast cell chymase and tryptase in abdominal aortic aneurysm formation.Mast cells in human and experimental cardiometabolic diseases.Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation.Role of cathepsin D activation in major adverse cardiovascular events and new-onset heart failure after STEMI.Serum tryptase detected during acute coronary syndrome is significantly related to the development of major adverse cardiovascular events after 2 years.Elastase-induced intracranial dolichoectasia model in mice.Mast cell degranulation in human periodontitis.Low-dose diet supplement of a natural flavonoid, luteolin, ameliorates diet-induced obesity and insulin resistance in mice.Modulation of Immune-Inflammatory Responses in Abdominal Aortic Aneurysm: Emerging Molecular Targets.
P2860
Q26825467-B49AD5FD-2A60-4979-9D1E-A5B94E711A8AQ27687421-F6C2F384-6AF9-44D2-8522-F5367E7EB813Q33602537-DAD61083-1E2C-4922-946F-79ECEB074EB3Q33734766-DCECFA72-D042-4A11-A6CD-15956B452604Q33969412-A93AC3E6-6D2A-4421-B740-D783B45B9C9AQ33991483-14118DD3-A652-4D35-A9BF-470B9C5088A4Q34110586-69EA44AE-2EE7-49C8-A55E-53509B7DD374Q34150874-9255BE7D-8B63-4B7B-9D58-0EA71A5D90FCQ34475790-29EB3BEA-3A36-4E79-8C74-3B5923C2925FQ35636731-DEAF4518-1745-4135-908C-40A024A1AEA9Q35851900-13528F3C-5C86-4CAF-9375-74497A8D138EQ35868279-94BEF414-D93A-44EB-A750-64C599DE2DC5Q35868633-89AA0588-0AEB-4181-B235-42D0417F0666Q36380781-D8FD550F-4BFA-4876-973C-8FF06CAA4CF1Q36404955-18A3DDBE-62C2-4E64-9E21-BDB52C16D9E3Q36619430-F0D61E12-9D67-4974-8B72-DAF51E642A5DQ36630944-E33F26D8-0D6F-46CD-9FE3-326A080F659AQ37047173-6EA78352-0402-422D-B67F-8A4604941007Q37104776-36B9CCC3-9AB4-4678-A93B-F92EF9C9FD39Q37578873-0304D775-B305-4E77-B2E3-394EC5D4708FQ37602518-4A61972C-A7D9-4765-BBFD-C737017F1590Q37946664-1C26B99F-1F9C-49E1-AF67-637C4AB56420Q38035575-C41ADBB1-B53A-4A52-900F-3B8F905EE852Q38563903-B1A51620-FA40-4E4D-B02E-423F878D5CB1Q39741685-7010DD6F-9C39-465F-8210-A41D40CD3248Q41016263-A4CAC1C7-1DBF-41EA-BA16-6ED36C216CE7Q41541775-8E86A0F0-CC4D-43A1-B382-E49A3FC24072Q48371028-3010EC4D-7ED2-416D-9A53-1D74351FCD9BQ50248557-1692CBDC-06D7-4107-8520-A64A2E647990Q53589878-0D175826-A360-4069-ACE0-097F7594D757Q55407912-EA87A364-8462-483A-99CB-8AB95508BAF0
P2860
Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation
@ast
Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation
@en
type
label
Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation
@ast
Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation
@en
prefLabel
Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation
@ast
Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation
@en
P2093
P2860
P50
P1433
P1476
Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation
@en
P2093
Galina K Sukhova
Guo-Ping Shi
Jiusong Sun
Mark Sinnamon
Richard L Stevens
Robert W Thompson
P2860
P304
P356
10.1161/CIRCRESAHA.111.243758
P577
2011-04-14T00:00:00Z